PIZZOLO, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 23.270
EU - Europa 21.843
AS - Asia 13.408
SA - Sud America 1.708
AF - Africa 159
OC - Oceania 39
Continente sconosciuto - Info sul continente non disponibili 19
Totale 60.446
Nazione #
US - Stati Uniti d'America 22.968
RU - Federazione Russa 6.968
GB - Regno Unito 6.175
SG - Singapore 5.616
CN - Cina 4.696
IT - Italia 1.582
SE - Svezia 1.513
BR - Brasile 1.442
DE - Germania 1.274
FR - Francia 1.224
IE - Irlanda 1.100
HK - Hong Kong 1.094
FI - Finlandia 1.075
VN - Vietnam 619
KR - Corea 429
UA - Ucraina 409
JP - Giappone 172
CA - Canada 155
IN - India 148
TR - Turchia 138
BE - Belgio 115
AR - Argentina 105
MX - Messico 90
BD - Bangladesh 75
ID - Indonesia 75
NL - Olanda 72
PL - Polonia 69
IR - Iran 61
ES - Italia 57
ZA - Sudafrica 55
IQ - Iraq 46
EC - Ecuador 45
PK - Pakistan 37
UZ - Uzbekistan 33
AU - Australia 29
CZ - Repubblica Ceca 27
CO - Colombia 25
VE - Venezuela 25
LT - Lituania 23
MA - Marocco 23
AT - Austria 22
CH - Svizzera 22
PY - Paraguay 22
RO - Romania 21
AE - Emirati Arabi Uniti 18
AZ - Azerbaigian 18
IL - Israele 17
PE - Perù 17
BG - Bulgaria 15
NP - Nepal 14
DZ - Algeria 13
EG - Egitto 13
EU - Europa 13
KG - Kirghizistan 12
CL - Cile 11
KE - Kenya 11
BO - Bolivia 10
JO - Giordania 10
PA - Panama 10
SA - Arabia Saudita 10
NZ - Nuova Zelanda 9
TN - Tunisia 9
KZ - Kazakistan 8
LV - Lettonia 8
TT - Trinidad e Tobago 8
AL - Albania 7
CR - Costa Rica 7
HU - Ungheria 7
LB - Libano 7
DK - Danimarca 6
DO - Repubblica Dominicana 6
JM - Giamaica 6
PT - Portogallo 6
SN - Senegal 6
A2 - ???statistics.table.value.countryCode.A2??? 5
KW - Kuwait 5
NO - Norvegia 5
TG - Togo 5
UY - Uruguay 5
BH - Bahrain 4
BJ - Benin 4
BY - Bielorussia 4
CI - Costa d'Avorio 4
EE - Estonia 4
HN - Honduras 4
LA - Repubblica Popolare Democratica del Laos 4
MD - Moldavia 4
MY - Malesia 4
OM - Oman 4
PH - Filippine 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
TW - Taiwan 4
AM - Armenia 3
BW - Botswana 3
GT - Guatemala 3
HR - Croazia 3
LK - Sri Lanka 3
LU - Lussemburgo 3
ME - Montenegro 3
Totale 60.385
Città #
Southend 5.299
Jacksonville 3.686
Singapore 2.785
Chandler 2.484
Dallas 2.367
Moscow 2.162
Woodbridge 2.116
Ashburn 1.879
Ann Arbor 1.394
Houston 1.191
Dublin 1.098
Hong Kong 1.086
Beijing 620
The Dalles 498
Wilmington 472
Lawrence 445
Princeton 445
Jinan 444
Nanjing 413
Los Angeles 408
New York 366
Shenyang 353
Buffalo 264
Hebei 229
Ho Chi Minh City 205
Tianjin 204
Verona 202
Boardman 201
Sindelfingen 185
Munich 179
Helsinki 165
Columbus 156
Changsha 153
Zhengzhou 153
Nanchang 142
Hanoi 141
Milan 141
São Paulo 136
Haikou 131
Hangzhou 124
Ningbo 124
Taizhou 113
Brussels 110
Jiaxing 107
Santa Clara 102
Guangzhou 95
Seattle 95
Tokyo 92
Philadelphia 87
Redondo Beach 86
Taiyuan 86
Washington 80
Turku 79
Council Bluffs 78
Falls Church 75
Seoul 74
Norwalk 71
Lancaster 66
San Jose 63
San Francisco 61
London 60
Rome 59
Dearborn 57
Fuzhou 57
Auburn Hills 56
Brooklyn 54
Toronto 54
Düsseldorf 51
Warsaw 51
Montreal 50
Redmond 49
Chicago 48
Denver 48
Stockholm 48
Fairfield 47
Lanzhou 46
Rio de Janeiro 44
Jakarta 43
Chennai 41
Frankfurt am Main 40
Boston 39
Atlanta 34
Dong Ket 30
Phoenix 30
Cambridge 29
Bologna 28
Leawood 28
Orem 28
Tashkent 28
Poplar 27
Redwood City 27
Brasília 26
Curitiba 26
Haiphong 26
Amsterdam 25
Manchester 25
Belo Horizonte 24
Da Nang 24
Johannesburg 24
Kochi 24
Totale 38.421
Nome #
La citometria a flusso in Ematologia: aspetti tecnici e metodologici 457
Immunocitologia e immunoistologia delle cellule midollari normali e neoplastiche 420
Preferential release of high amounts of interleukin-8 by myeloid blasts showing monocytic differentiation 418
Valutazione immunofenotipica della malattia minima residua (MRD) nella leucemia acuta linfoblastica dell'adulto 311
Leucemia linfatica cronica/linfoma linfocitico (LLC): l'espressione di ZAP-70, analizzata alla diagnosi su biopsia ossea, è un importante fattore prognostico 295
Interferon-alpha-engineered Multipotent Mesenchymal Stromal Cells for the treatment of myeloma 289
a (p55) and b (p75) chains of interleukin-2 receptor are expressed by AML blasts 267
A simplified immunological approach to the diagnosis of chronic lymphocytic leukaemia and other lymphoproliferative disorders 266
IFNalpha-producing bone marrow mesenchymal stem cells (BM-MSCs) contrast tumor growth in a mouse myeloma model. 261
Alpha (p55) and beta (p75) chains of the interleukin-2 receptor are expressed by AML blasts 252
Acute lymphoblastic leukemia (ALL) in elderly patients receiving intensive treatment. Experience in 26 consecutive patients 247
DEATH RECEPTOR 3 EXPRESSION AND SERUM LEVEL OF SOLUBLE TL1A CORRELATE WITH INDOLENT, EARLY STAGE B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA 241
Acute lymphoblastic leukaemia after radiotherapy and adjuvant chemotherapy (CMF) for breast cancer. 237
Abnormal expansions of polyclonal large to small size granular lymphocytes: reactive or neoplastic process? 236
Endothelin B Receptor (Etbr) expression by human malignant plasma cells: preliminary evidence for a role of the endothelin axis in multiple myeloma. 234
A rapid immunostaining method for frozen sections 231
B-cell chronic lymphocytic leukemia cells espress functional death receptor 3 following stimulation of the B cell receptor 231
Association between B-cell receptor responsiveness and disease progression in B-cell chronic lymphocytic leukemia: results from single cell network profiling studies 231
[Lung diseases during the course of systemic diseases: current clinico-radiological problems (proceedings)] 228
Prognostic value of serum markers of established impact on prognosis in relation with ZAP-70 expression in B-CLL patients 225
A study of the crosstalk between CD30 and CXCR4 224
CAL2 Monoclonal Antibody Is a Rapid and Sensitive Assay for the Detection of Calreticulin Mutations in Essential Thrombocythemia and May Provide Prognostic Informations 223
Analysis of B-cell receptor signal transduction in B-cell chronic lymphocytic leukemia by phosphospecific flow-cytometry 221
Alpha-interferon activates the natural killer system in patients with hairy cell leukemia 218
Abnormal expression of the p53-binding protein MDM2 in Hodgkin's disease 218
Role of stromal cell-mediated Notch signaling in CLL resistance to chemotherapy 217
Acute leukemia and pregnancy. Case report 216
Induction of neural-like differentiation in human mesenchymal stem cells derived from bone marrow, fat, spleen and thymus 215
A proliferation-inducing ligand (APRIL) serum levels predict time to first treatment in patients affected by B-cell chronic lymphocytic leukemia 212
Alpha-interferon activated cytotoxic lymphocytes in hairy cell leukemia patients: evaluation of cytotoxic events 211
Expression and function of the TL1A/DR3 axis in chronic lymphocytic leukemia 211
NON-CANONICAL NOTCH SIGNALING IN T-ALL: A PHOSPHO-FLOW CYTOMETRY STUDY 208
A preliminary experience with the HyperCHiDAM Verona intensive chemotherapy regimen in heavily pretreated refractory Hodgkin's lymphoma 208
A novel large-sized BCR-ABL transcript in a case of chronic myeloid leukaemia characterised by a favourable clinical course. 208
Increased levels of soluble interleukin-2 receptor in the serum of patients with human immunodeficiency virus infection 207
HB-EGF/HER -1 SIGNALLING IN BONE MARROW MESENCHYMAL STEM CELLS: INDUCING CELL EXPANSION AND PREVENTING REVERSIBLY MULTI-LINEAGE DIFFERENTIATION 206
Homing and Efficacy Assessment of interferon-alpha-engineered mesenchymal stromal cells in a mouse plasmocytoma model 204
SINGLE-CELL PROFILES OF B-CELL RECEPTOR PHOSPHO-PROTEIN NETWORKS ASSOCIATED WITH PROGNOSIS AND PROGRESSION IN CHRONIC LYMPHOCYTIC LEUKEMIA 203
Serum levels of soluble interleukin-2 receptor in hairy cell leukaemia: a reliable marker of neoplastic bulk 202
EXPRESSION AND FUNCTIONAL ACTIVITY OF DEATH RECEPTOR 3 IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA 201
BCR-signaling profiles associated with prognosis and progression in B-CLL 201
Alpha-interferon activates the natural killer system in patients with hairy cell leukemia 199
Efficacy assessment of interferon-alpha-engineered mesenchymal stromal cells in a mouse plasmacytoma model 199
Bone marrow stromal cells and the upregulation of interleukin-8 production in human T-cell acute lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-kappaB and JNK/AP-1 pathways 198
CXCL8 and interleukin-6 in B-cell chronic lymphocytic leukemia are up-reuglated through the activity of CXCL12 198
CXCL12-MEDIATED NF-KAPPAB AND C-JUN ACTIVATION REGULATES INTERLEUKIN 8 PRODUCTION IN HUMAN T-LYMPHOBLASTIC LEUKEMIA 198
Novel stem/progenitor cells with neuronal differentiation potential reside in the leptomeningeal niche 197
Cellular senescence markers p16INK4 and p21CIP1/WAF are predictors of Hodgkin's lymphoma outcome 197
The diagnostic value of serum copper levels and other hematochemical parameters in malignancies 196
Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosis 196
Blastic OKT6-positive proliferation preceding malignant histiocytosis 194
ANTI-MÜLLERIAN HORMONE AND ANTRAL FOLLICLE COUNT REVEAL A LATE IMPAIR- MENT OF OVARIAN RESERVE IN PATIENTS UNDERGONE LOW GONADOTOXIC REGIMENS FOR HAEMATOLOGICAL MALIGNANCIES 194
Absence of prognostic impact of CD13 and/or CD33 antigen expression in adult acute lymphoblastic leukemia. Results of the GIMEMA ALL 0496 trial 193
Erectile Dysfunction after Allogeneic Hematopoietic Stem Cell Transplant: Results from a Single Center Experience 193
Bone marrow-, but not thymus-, derived stromal cells inhibit spontaneous apoptosis and induce proliferation in blasts of T-lineage ALL 192
Double productive immunoglobulin sequence rearrangements in patients with chronic lymphocytic leukemia 191
[Haemolytic anaemia associated with acquired deficiency of erythrocyte glutathione peroxidase: use of sodium selenite to correct the enzyme defect (author's transl)] 188
CXCL8/interleukin 8 in B-cell chronic lymphocytic leukemia is up-regulated through the activity of the CXCL12/CXCR4 axis 187
G-CSF-stimulated neutrophils are a prominent source of functional BLyS 187
Caratterizzazione immunofenotipica: principi ed applicazioni in Ematologia 186
Immunohistochemical differentiation of follicular lymphoma from florid reactive follicular hyperplasia with monoclonal antibodies reactive on paraffin sections 185
Cellular antigens and soluble molecules and cytokine receptors in leukemia and lymphoma: biological role and clinical applications 185
BCR-signaling profiles associated with prognosis and progression in B-CLL 185
Rapid reconstitution of functionally active 6-sulfoLacNAc(+) dendritic cells (slanDCs) of donor origin following allogeneic haematopoietic stem cell transplant 185
[Immunology of the lymphatic follicle] 184
Espressione e ruolo funzionale di CD30/CD30L e Fas/FasL in cellule endoteliali umane 184
Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels 184
An unusual case of acute leukaemia 183
Natural killer cell function and lymphoid subpopulations in acute non-lymphoblastic leukaemia in complete remission 183
Autoimmune complications are frequent in splenic and nodal marginal zone lymphomas 182
Allergen specific immunotherapy is safe and effective in patients with systemic mastocytosis and hymenopteria allergy 181
Activated T cells with immunoregulatory functions at different sites of involvement in sarcoidosis. Phenotypic and functional evaluations 180
REDOX SIGNALING HYPERSENSITIVITY DISTINGUISHES CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS WITH FAVORABLE PROGNOSIS 180
Expression of extracellular matrix molecules, proliferation markers and cyclin-dependent kinase inhibitors in inflamed tissues 179
BONE MARROW-DERIVED STROMAL CELLS INHIBIT SPONTANEOUS APOPTOSIS IN NORMAL AND NEOPLASTIC THYMOCYTES 179
Expression and role of CD30/CD30L and Fas/FasL in human endothelial cells 176
Soluble interleukin-2 receptors in the sera of patients with hairy cell leukemia: relationship with the effect of recombinant alpha-interferon therapy on clinical parameters and natural killer in vitro activity 176
Ceftazidime and amikacin as empiric antibiotic therapy of febrile granulocytopenic patients with hematological malignancies. Report of 171 consecutive episodes 176
Detection of calbindin-D immunoreactivity in human follicular dendritic cells 176
G-CSF-stimulated neutrophils are a prominent source of functional B-lymphocyte stimulator (BLyS) 176
Biological prognostic factors in indolent lymphoma 175
PROGNOSTIC VALUE OF SERUM THYMIDINE KINASE LEVEL AND ZAP-70 EXPRESSION DETECTED BY IMMUNOHISTOCHEMISTRY ON BONE MARROW BIOPSIES IN B-CLL: COMPARATIVE ANALYSIS 175
AIDA 0493 protocol for newly diagnosed acute promyelocytic leukemia: very long-term results and role of maintenance 174
METHODOLOGICAL APPROACH TO MINIMAL RESIDUAL DISEASE DETECTION BY FLOW CYTOMETRY IN ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA 174
Espressione del CD30 ligando sulle cellule di differenti neoplasie ematologiche leucemiche 173
Neoplastic epithelial cells in a subset of human thymomas express the B cell-associated CD20 antigen 173
Estimated 6-year event-free survival of 55% in 60 consecutive adult acute lymphoblastic leukemia patients treated with an intensive phase II protocol based on high induction dose of daunorubicin 172
Prognostic factors in acute non-lymphocytic leukemia with respect to treatment response 171
Integrated single cell network profiling data of ERK signaling and mutations of SF3B1 gene refine prognosis in chronic lymphocytic leukemia 171
P21/WAF1 cyclin-kinase inhibitor expression in non-Hodgkin’s lymphomas and Hodgkin’s disease: a reliable marker of p53 tumor suppressor gene function 171
B cells in chronic lymphocytic leukaemia. Comparative analysis of blood and bone marrow 170
Hyaline-vascular type of Castleman's disease (angiofollicular lymph node hyperplasia) with monotypic plasma cells. An immunohistochemical study with monoclonal antibodies 170
Human neutrophils interact with both 6-sulfo LacNAc+ DC and NK cells to amplify NK-derived IFN{gamma}: role of CD18, ICAM-1 and ICAM-3 170
Jagged-1, Jagged-2 and DLL-1 are the elements of Notch signaling mainly responsible for the antiapoptotic effect on B-lineage acute lymphoblastic leukemia exerted by bone marrow Mesenchymal Stem Cells 170
IL-8 mRNA expression and IL-8 production by acute myeloid leukemia cells 169
Common acute lymphoblastic leukaemia-lymphoma expressing cytokeratin: a case report 169
Fluoride resistant alpha-naphthyl acetate esterase and combined enzyme histochemistry in the study of normal and pathologic lymphoid tissues 169
Interferon-alpha-engineered Multipotent Mesenchymal Stromal Cells for the treatment of myeloma 169
Soluble interleukin-2 receptors in the serum of patients with Hodgkin's disease 168
Highly concentrated urine-purified Tac peptide fails to inhibit IL-2-dependent cell proliferation in vitro 168
Totale 20.734
Categoria #
all - tutte 183.615
article - articoli 131.752
book - libri 0
conference - conferenze 49.497
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.366
Totale 367.230


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.405 0 0 0 0 0 613 58 419 372 40 700 203
2021/20223.812 331 1.091 44 264 212 118 76 203 135 142 389 807
2022/20237.250 582 583 658 1.295 744 1.768 59 473 771 42 181 94
2023/20243.451 174 297 300 391 356 501 188 431 18 124 409 262
2024/20258.611 600 595 220 1.458 472 279 318 383 1.323 475 706 1.782
2025/202616.254 1.866 1.831 1.905 3.535 5.636 1.481 0 0 0 0 0 0
Totale 60.759